换一批Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.
第一作者：
Michael A,Morgan
第一单位：
Institute of Experimental Hematology, Hannover Medical School, Hanover, Germany.;REBIRTH Research Center for Translational Regenerative Medicine, Hannover Medical School, Hanover, Germany.
作者：
主题词
动物(Animals);临床试验(主题)(Clinical Trials as Topic);综合疗法(Combined Modality Therapy);基因转移技术(Gene Transfer Techniques);遗传工程(Genetic Engineering);遗传载体(Genetic Vectors);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);杀伤细胞, 天然(Killer Cells, Natural);肿瘤(Neoplasms);多潜能干细胞(Pluripotent Stem Cells);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);干细胞移植(Stem Cell Transplantation);T淋巴细胞(T-Lymphocytes);移植, 自体(Transplantation, Autologous);移植, 同种(Transplantation, Homologous)
DOI
10.3389/fimmu.2020.01965
PMID
32903482
发布时间
2021-04-30
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
